FDA NDC Directory · JSON-LD · Markdown

Hydroxyzine Pamoate

NDC 0555-0302 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA088487
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (50 mg/1)
Marketing started19840701
Package count2

External sources

Source: openFDA. Public-domain (CC0).